Core Viewpoint - The collaboration between Insilico Medicine and Shenzhen Hengtai Biotechnology aims to accelerate the global development of ISM8969, a novel NLRP3 inhibitor for treating central nervous system diseases [1] Group 1: Partnership Details - Insilico Medicine and Hengtai Biotechnology have entered into a co-development agreement for the ISM8969 project [1] - Insilico Medicine grants Hengtai Biotechnology 50% rights for research, development, registration, production, and commercialization of ISM8969 globally [1] Group 2: Financial Aspects - Insilico Medicine is set to receive over HKD 500 million in total prepayments and milestone payments, including an initial payment of HKD 78 million expected within 30 days of the agreement's effective date [1] Group 3: Development Responsibilities - Insilico Medicine will lead the early clinical development of ISM8969, including the submission of new drug clinical trial applications and conducting Phase I clinical trials for Parkinson's disease indications [1] - Hengtai Biotechnology will take charge of subsequent global clinical research, regulatory registration, and commercialization efforts [1]

Core Insights - The first month of operation under the Hainan Free Trade Port has shown strong performance in key metrics, indicating effective market activation and accelerated development momentum [2] Group 1: Trade and Economic Data - In the first month, Haikou imported "zero tariff" goods worth 29.94 million yuan, accounting for 3.97% of the province's total, primarily consisting of medical devices and production equipment [2] - The value of domestic sales of processed goods exempt from tariffs reached 41.42 million yuan, representing 48.2% of the province's total, with a tariff exemption of 1.32 million yuan, mainly in chemical products and food [2] - The total value of goods subject to relaxed trade management measures was 34.7 thousand yuan, accounting for 100% of the province's total, primarily including endoscopic equipment [2] - The first month saw the addition of 15,800 new business entities in Haikou, a year-on-year increase of 12.62%, representing 57.92% of the province's total [2] Group 2: Tourism and Passenger Traffic - Duty-free sales in the offshore market reached 2.24 billion yuan, a year-on-year increase of 44.4%, setting a new record for the same period [3] - Meilan Airport operated 39 international routes, with a total of 1,226 flights in the first month, a year-on-year increase of 28.5%, transporting 189,000 international and regional passengers, a 50% increase [3] - The international cargo transport on 5 operational routes amounted to 955 tons, reflecting a year-on-year growth of 9% [3] - The number of foreign visitors entering without a visa reached 7,681, a year-on-year increase of 31.3% [3] Group 3: Customs and Port Efficiency - Haikou was the first city in the province to complete the passage of "zero tariff," processed goods exempt from tariffs, and goods under relaxed trade management measures through regulatory channels [3] - In the first month, Haikou's four "second-line ports" processed 219 shipments of processed goods exempt from tariffs, covering 20 beneficiary enterprises in key sectors such as medical devices and food processing [3] - The average time for container trucks to pass through Haikou port has been reduced to 18 seconds, achieving "second-level customs clearance," significantly saving time and costs for businesses and logistics [4] - Approximately 80,399 domestic freight vehicles passed through the centralized inspection area in the first month, averaging about 2,590 vehicles per day, validating the port's capacity [4]

首个管线已进入II期临床阶段。 本文为IPO早知道原创 作者｜ C叔 微信公众号｜ipozaozhidao 据IPO早知道消息，近日，浙江德进生物医药科技有限公司（下称"德进生物"）完成数千万元A轮融 资，由弘晖基金领投，凯乘资本担任首席财务顾问并继续负责后续融资。融资金额将主要用于推进公 司核心产品——基于合成生物学平台开发的重组肉毒素的临床研究、产业化基地建设及国际化布局。 德进生物是一家专注于重组肉毒素研发、生产和销售的创新企业，致力于将合成生物学技术应用于药 学领域，研发和提供性价比卓越的肉毒素系列产品，最终成为该品类主要供应商之一。 在技术创新层面，基于公司自有专利技术，德进生物的首个管线"DJ-01注射剂"已进入II期临床阶 段，安全性和有效性良好；该产品基于基因工程菌株设计与构建技术平台开发，显著降低传统肉毒素 生产中突出的生物安全风险，在大幅提高产品纯度和质量的同时还能保持极具竞争力的成本，充分发 挥出工程菌株设计平台以及重组蛋白技术优势。 在产业化层面，德进生物核心团队成员工作时间均在十年以上，在重组蛋白研发、生物药开发、高活 性药厂建设、药品生产以及医美市场开拓领域拥有丰富经验。在公司建立 ...

Core Insights - Guangzhou's government work report emphasizes the focus on three key industries: artificial intelligence, marine economy, and biomedicine, positioning them as "winning track," "strategic track," and "decisive track" respectively, marking a significant shift in the city's economic development strategy [1][2][11] Industry Focus - The report highlights that Guangzhou's economic competitiveness is transitioning from traditional factor-driven growth to technology innovation and high-end industry-driven growth, as evidenced by significant investments and achievements in advanced manufacturing and AI [1][4] - Guangzhou has established itself as a hub for artificial intelligence with approximately 2,200 AI-related companies, over 25% of which have a scale exceeding 100 million yuan, covering the entire value chain from foundational to application layers [3][4] - In biomedicine, Guangzhou's R&D expenditure reached 3.847 billion yuan in 2025, with an investment intensity of 7.39%, the highest in the city's industrial sectors, indicating strong growth potential [5][7] - The marine economy is characterized by a robust shipbuilding industry, with a total output value exceeding 490 billion yuan in 2024, and a shipbuilding capacity of over 5.5 million deadweight tons, showcasing Guangzhou's historical maritime strengths [7][11] Strategic Initiatives - The city plans to implement the "Artificial Intelligence+" initiative in 2026, aiming to accelerate the development of the marine economy and biomedicine, while building a modern industrial system centered around advanced manufacturing [2][10] - Guangzhou's government is establishing a dedicated AI development bureau, the first of its kind in the country, to streamline management and enhance strategic collaboration in the AI sector [9] - The report outlines specific actions for 2026, including the establishment of national AI application pilot bases, optimization of computing infrastructure, and the development of high-quality data sets to support AI applications [10][11] Collaborative Development - The three key industries are interrelated, with AI serving as an enabling technology, the marine economy providing resources and application scenarios, and biomedicine representing high-value outputs, indicating a holistic approach to industrial development [11][12] - The focus on these industries reflects a long-term strategic vision for Guangzhou, prioritizing sustainable growth and innovation over short-term gains, aligning with national competitiveness goals [11][12]

Core Viewpoint - Wuhan Municipal Government has released a plan to accelerate the cultivation of R&D enterprises and promote the industrialization of R&D from 2025 to 2027, aiming to strengthen the city's R&D service foundation and establish 30 municipal concept verification centers and 200 pilot platforms by 2027 [1][2] Group 1: R&D Enterprise Cultivation - The plan outlines 5 areas and 18 measures to foster R&D enterprises, accelerate R&D industrialization, and support the launch of new business models and technologies [2][3] - By 2027, the number of municipal R&D centers is expected to exceed 1,200, with over 300 R&D enterprises and more than 30 foreign R&D centers established [2][3] Group 2: R&D Investment and Support - The plan includes a "seedling plan" for startup tech companies, selecting 200 high-growth startups annually for up to 500,000 yuan in funding over three years for R&D activities [4] - For newly recognized high-tech enterprises, rewards of 100,000 yuan and 50,000 yuan will be provided for first-time and re-recognition, respectively [4] Group 3: R&D Ecosystem Optimization - Measures to enhance R&D support services include deepening university-industry cooperation and improving R&D support services, with a reward of up to 1 million yuan for technology transaction achievements [3] - The plan emphasizes attracting R&D talent, enhancing financial support for innovation, and promoting the application of new technologies [3][5] Group 4: Cluster Development - The plan aims to create 3-5 high-level R&D enterprise clusters in various districts, focusing on sectors such as biomedicine, optical electronics, and new energy vehicles [5] - Districts are encouraged to develop specific support policies, with financial rewards for recognized national small and medium-sized enterprise clusters [5]

Group 1 - The core point of the news is that Insilico Medicine (03696) has entered into an exclusive licensing and co-development agreement with Shenzhen Hengtai Biotechnology Co., Ltd. for the ISM8969 project, aimed at accelerating the global development of a novel oral NLRP3 inhibitor for central nervous system diseases [1][2] - Under the agreement, Insilico will grant Hengtai the rights to research, develop, register, produce, and commercialize ISM8969 globally, with both parties holding 50% global rights to the project [1] - Insilico is set to receive up to $66 million (approximately HKD 514.8 million) in upfront and milestone payments, including an initial payment of $10 million (approximately HKD 78 million) expected within 30 days of the agreement's effective date [1] Group 2 - ISM8969 is positioned as a potential best-in-class NLRP3 inhibitor, discovered and optimized through Insilico's proprietary generative chemistry engine, Chemistry42 [2] - Preclinical studies have shown that ISM8969 exhibits excellent efficacy and safety, demonstrating significant anti-inflammatory activity across various disease models [2] - The compound has ideal blood-brain barrier (BBB) penetration capabilities, which may provide potential benefits for treating neuroinflammatory-related diseases [2]

Core Viewpoint - The "15th Five-Year Plan" for Shanghai emphasizes enhancing the city's role as a global economic and financial center, focusing on high-quality development and the construction of a modern industrial system [2][4][6]. Group 1: Five Centers Development - The plan outlines the construction of "five centers" as a key strategy for Shanghai's modernization, which includes enhancing its international economic, financial, trade, shipping, and technological innovation centers [6][7]. - Specific initiatives include building a world-class high-end industrial cluster, establishing a global RMB asset allocation center, and enhancing the city's trade hub functions [6][9]. Group 2: Economic and Social Development Goals - The main goals for the "15th Five-Year" period include achieving significant high-quality development, elevating urban core functions, and enhancing social civilization levels [4][5]. - By 2035, Shanghai aims to double its per capita GDP compared to 2020 and fully upgrade the functions of the "five centers" to reach international leading levels [4][5]. Group 3: Modern Industrial System - The plan emphasizes the importance of maintaining a reasonable proportion of manufacturing within Shanghai's economy, identifying it as a foundation for the city's international economic status [8]. - It outlines a modern industrial system framework categorized into traditional, leading, emerging pillar, and future industries, aiming for a robust manufacturing backbone [8][10]. Group 4: High-End Service Industry - The development of high-end service industries is highlighted as crucial for enhancing Shanghai's international influence, with specific measures to strengthen the global supply chain and trade hub functions [9]. - The plan also includes fostering world-class enterprises as a dedicated task, providing guidance for the growth of large, medium, and small enterprises [9].

Group 1 - Chengdu and the Yangtze River Delta have initiated a series of cooperative agreements, including three industrial parks in Wuhou District, Pidu District, and Jintang County, which will collaborate with innovation platforms, research institutes, and industry associations from the Yangtze River Delta to build an industrial synergy and talent cultivation platform [1] - Six key industrial projects from the Yangtze River Delta have been signed, covering areas such as low-altitude economy, artificial intelligence, biomedicine, and advanced energy [1] - The establishment of an innovation collaborative platform between the Zhongke Yangtze River Delta Artificial Intelligence Innovation Center and Wuhou District aims to support cross-regional joint research and achievement transformation, facilitating the orderly flow of talent, technology, and data [1] Group 2 - A comprehensive job fair was held, featuring over 100 key employers from Chengdu focusing on cutting-edge fields such as artificial intelligence, software and information services, advanced energy, and new materials, releasing more than 600 quality job positions with the highest annual salary reaching 1.5 million [1] - Chengdu Jinyang High-tech Development Co., Ltd. is seeking software architects and product managers, emphasizing the importance of talent from the electronic information industry in Hangzhou for overcoming technical bottlenecks [2] - The job fair showcased 147 local products, creating an immersive interactive experience, and included a "talent achievement exhibition" displaying high-level talent innovation outcomes alongside cultural and culinary showcases from the region [2]

Group 1 - The core viewpoint is that during the "14th Five-Year Plan" period, Xiamen's capital market has achieved significant development, characterized by scale expansion, innovation empowerment, and cross-strait integration, laying a solid foundation for the "15th Five-Year Plan" [1] Group 2 - By the end of 2025, the number of listed companies in Xiamen is expected to reach 70, accounting for nearly 40% of the province, with a total market value exceeding 903 billion yuan, representing a 43% increase from the end of 2020 [1] - The trading volume in securities and futures is projected to reach 15.05 trillion yuan and 16.17 trillion yuan respectively by 2025, indicating a significant increase in market activity [1] - The private equity fund scale has reached 214.4 billion yuan, and the scale of corporate bonds and asset securitization products has reached 220 billion yuan, showcasing a more complete multi-level capital service system [1] Group 3 - A total of 403.2 billion yuan has been raised during the "14th Five-Year Plan" period, primarily directed towards emerging industries such as software information and biomedicine [2] - The number of companies in the listing reserve has expanded to 597, and the first CVC mother fund in the country has been established, demonstrating significant progress in innovative bond issuance [2] - Research and development (R&D) spending by listed companies is expected to reach 11.25 billion yuan in 2024, with an average R&D intensity of 5.02% among 52 manufacturing and IT service companies [2] Group 4 - The construction of the first cross-strait capital market service base has shown remarkable results, with 7 Taiwan-funded listed companies in the region, accounting for 10.61% of the total number of Taiwan enterprises listed domestically [2] - The total amount of dividends during the "14th Five-Year Plan" period has increased 27 times, reflecting the strong performance of Taiwan-funded enterprises [2] - The Xiamen cross-strait equity trading center has showcased 1,124 enterprises on its "Taiwan-funded board," and the scale of Taiwan-funded private equity funds has reached 6.778 billion yuan [2] Group 5 - A comprehensive risk prevention system has been established, with 499 on-site inspections conducted and 28 administrative penalties issued during the "14th Five-Year Plan" period, amounting to 293 million yuan in fines [3] - Investor protection has been notably effective, with 1,308 investors receiving compensation of 224 million yuan through representative lawsuits [3] - Risks in key areas have been effectively mitigated, with issues such as fund occupation and illegal guarantees by listed companies being resolved, ensuring overall stability in the capital market [3]

Economic Growth Overview - In 2025, China's GDP grew by 5% year-on-year, surpassing 140 trillion yuan for the first time, with per capita GDP rising from $10,632 in 2020 to $13,953 in 2025, maintaining above $13,000 for three consecutive years [2][10] - The average annual GDP growth rate during the 14th Five-Year Plan period was 5.4%, significantly higher than the global average, marking a consistent increase in GDP total [4] K-shaped Growth Characteristics - The Chinese economy is exhibiting a "K" shaped growth pattern, with strong performance in sectors like equipment manufacturing and high-tech industries, while some enterprises remain cautious about market expectations [2][7] - Quarterly GDP growth rates showed a declining trend throughout 2025, indicating potential underlying issues in demand and economic momentum [7][8] Consumption and Investment Trends - In 2025, the total retail sales of consumer goods exceeded 50 trillion yuan, with a year-on-year growth of 3.7%, contributing 52% to economic growth, an increase of 5 percentage points from the previous year [5][6] - Fixed asset investment saw a decline of 3.8% year-on-year, highlighting challenges in sustaining investment growth [8] Innovation and High-tech Sector Performance - R&D expenditure intensity reached 2.8%, surpassing the OECD average for the first time, and China's innovation index ranked among the top ten globally [5] - The production of high-tech products, such as 3D printing equipment and industrial robots, saw significant growth, indicating a robust high-tech sector [5] Future Economic Projections - Experts suggest maintaining a GDP growth target of around 5% for 2026 to support the long-term goal of reaching a per capita GDP of $20,000 by 2035 [3][11] - The potential economic growth rate is projected to decline to around 4.2% by 2030, emphasizing the need for effective policy measures to manage economic transitions [12]